chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report based on information received by Pfizer from Merck & Co., Inc., (manufacturer reference number 00840225). A contactable pharmacist reported an unspecified patient received a dose of PREVNAR 13 (lot number and expiration date unknown by reporter) on an unspecified date in Apr2017. Pharmacist reported the patient was diagnosed with pneumonia "since receiving" dose of PREVNAR 13, date unspecified. No additional information provided. No follow-up attempts are possible, information about batch number cannot be obtained.; Sender's Comments: Based on the information currently available, a lack of efficacy (pneumonia  occurred after the vaccination schedule with pneumococcal 13-valent conjugate vaccine) in this patient cannot be completely excluded.
Foster mother states after getting most recent vaccines, patient developed fever, congestion, abnormal movements. He was unable to hold his head up, was lethargic, "whining like a puppy," and eyes were unfocused. She took him to the ED 6/1/22, but they were unable to do anything for the patient. She states he seems to be feeling better, but she would like the reaction documented and to discuss with provider the best way to proceed with vaccinations. PCP office received a call on 6/1/22 from patient's physical therapist reporting patient's eyes were not focusing, he had nystagmus, and he had lost weight. PT was concerned there was a neurological issue. PCP office directed them to ED. ED note from 6/1/22:  9 month old male with hx of neonatal abstinence syndrome, cerebral palsy, seizure disorder, was brought to the ED by his foster mother for general evaluation. She was advised by PT to to come to the ED for evaluation for possible seizure. While patient was at physical therapy today he seemed uncomfortable, had some rhythmic movements with bobbing his head and arching his back for a few seconds. Patient had immunizations 4 days ago and had a couple fevers after the shots. He also has runny nose and congestion for the last 5 days.
FEVER; CHILLS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included sulfa allergy, and latex allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 08-MAR-2021 11:00 to Left Arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 08-MAR-2021, the subject experienced fever. On 08-MAR-2021, the subject experienced chills. Laboratory data included: Body temperature (NR: not provided) 102 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills on 08-MAR-2021, and had not recovered from fever. This report was non-serious.
Describes painful, swelling to right arm injection site on 04/04/15 (date injection given) then on 04/05/15 developed bruising, pain, 04/06/15 area measures 1.74 x 1/25" with 04/06/15 dark purple bruising, swelling, itching, warm to touch.
47 year old female patient refers to the EMT feeling dizzy and began to present redness in the neck and chest 10 minutes after receiving her second dose of PFIZER. The EMT proceeded to take the patient to the observation area to take her vitals signs: BP 130/80, P, 99 saturation, respiration 19 and 74 DXT. Then, we performed IV access with normal saline 9% in the forearm and BENADRYL 50mg IV.
Dizziness, pain in chest, bodyaches recurring from late Friday afternoon to Monday morning, when symptoms began to subside.
Per Record: This patient was admitted to hospital on 8/11/2022 with 1 week of worsening of symptoms. Per record: Patient tested positive for COVID-19 on 8/5/2022 and was symptomatic of SOB, fever, chills, and increased anxiety since then. Per record this patient was Hypoxic on arrival with SpO2 78% on RA, improved to 96% on 6L O2 NC. Prior to the onset of symptoms patient had missed multiple dialysis sessions.  Per record, this patient was emergently dialyzed upon admission; shortness of breath worsened with hypoxia that was non-responsive to BiPAP.  Patient was intubated while in the ICU and also had an NSTEMI. After extubating patient has had periods of waxing and waning leukocytosis, and has also had multiple dialysis sessions. Ferritin 1117, procal 0.61. CXR shows fluid overload, R basilar opacity c/f atelectasis vs PNA. Patient was counseled about mortality benefits with steroids in COVID-related hypoxia, however she consistently declines this therapy. Per record, patient was afebrile, RR 22, 96% on 6L O2. No remdesivir per nephrology as patient is on hemodialysis. Per record, Pt was intubated on 08/12/2022 for acute hypoxic respiratory failure. Pt was noted to have rising troponin and evaluated by cardiology team with echocardiogram and plan was for an outpatient stress test. Patient received hemodialysis sessions as per nephrology recommendations. Pt was extubated on 0814/2022 and transitioned to bipap therapy. Pt was transferred to the floor on 08/20/2022 from the ICU. Code team was called just before 3:00 am. Upon arrival patient was sitting in the chair, unresponsive, with emergency protocol ongoing. Per record, this patient was noted to be in asystole initially and then was in V fib briefly for which patient was shocked and given 300m g IV amiodarone. Blood glucose level was greater than 200 gm/dl. Patient had significant yellowish secretions coming out of mouth and nose during ongoing CPR. Was intubated after placing NG tube during CPR. After approximately 18 minutes of CPR, there was no ROSC. Pt was pronounced dead on 8/25/22.
Started with mild red mark on face 3/21/22 and then woke with diffuse hives 3/22/22. Ongoing intermittent hives and some facial swelling since then. Some hand/feet swelling and joint pain (joint pain developed 3/27/22). Treated with antihistamines, steroids, and pain medications.
rt thigh w/sl red, indurated, sl warm area around site of inj 3 x 1 1/2" inguinal node;
Faint feeling, hot-flash-like symptoms... Feeling like my face was flushed, I was incredibly hot and had to take off my suit jacket and could not get cool. I felt I was burning up. This happened three times that day - ~10, ~11:30, ~4:30pm. I'm usually cold and the room temperatures were a confimred 72. I usually prefer 74.
Have had hives/itchy since June. Never in my life have I had consistent hives. Hives turn into bruises. Been through several doctors and specialists. Absolutely horrible. No one knows why this is happening to me.
WITHIN 12 HOURS OF ADMINISTRTION, ONSET OF HEADACHE, MUSCLE ACHE AND FATIGUE. 36 HOURS AFTER ADMINISTRATION: SAME SYMPTOMS BUT LESS. 60 HOURS AFTER ADMINISTRATION: FATIGUE AND MUSCLE ACHE. aSPIRIN TAKEN X 4 A DAY FOR RELIEF. SYMPTOMS NOT SEVERE ENOUGH TO SEE PHYSICIAN.
Patient contracted COVID-19 2 weeks following 1st vaccine dose; Patient contracted COVID-19 2 weeks following 1st vaccine dose; This is a spontaneous report from a contactable other healthcare professional (HCP). A 45-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), intramuscularly, administered in the left arm on 25Mar2021 at 18:00 at the age of 45 years old (Batch/Lot Number: En8730, Expiration date: Unknown) as the 1st dose, single for COVID-19 immunization. The facility where the most recent COVID-19 vaccine was administered was at the pharmacy or drug store. The patient's medical history was not reported. Concomitant medication included finasteride taken for an unspecified indication, start and stop date were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient contracted COVID-19 2 weeks following 1st vaccine dose on 08Apr2021 at 12:00 with polymerase chain reaction (PCR), Covid test via nasal swab: positive post vaccination on 10Apr2021. The reporter assessed the event as non-serious. The adverse event (ae) resulted in a doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the adverse event. The patient recovered from the event on an unspecified date in 2021.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. However, full immunity is only expected 7 days after the second dose.
body aches/achy; Headache; not feeling great; congestion; Two hours after receiving the vaccine she had a runny nose; 4 hours after she was experiencing some itching in the back of her throat, on her chest, and on her back.; 4 hours after she was experiencing some itching in the back of her throat, on her chest, and on her back.; Allergic reaction; heated flushing feeling in her cheeks; This is a spontaneous report from a contactable Other healthcare professional (HCP) reporting for herself. A 56-year-old female patient  received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: E49899), via an unspecified route of administration on 27Dec2020 at single dose for covid-19 immunization. It was the first dose. Medical history included allergic to shellfish. There were no concomitant medications. Two hours after receiving the vaccine on 27Dec2020 she had a runny nose. Then, 4 hours after she was experiencing some itching in the back of her throat, on her chest, and on her back. She didn't have a rash. She did feel like what she was having was an allergic reaction. She had a heated flushing feeling in her cheeks. It was very similar to the reaction she has when she eats shellfish. The allergic side effects have subsided. When she was having the reaction she took one Claritin, and it ended up going away. Yesterday the 28Dec2020. She was also achy. She had a headache, and body aches. She wasn't feeling great, but they have gone away. She also had congestion. Those all started the 28Dec2020 in the morning. The outcome of the events was recovered on an unknown date in Dec2020.
No additional AE; PEDVAXHIB was administered post temperatme excursion.; This spontaneous report was received from a registered nurse, referring to a patient of unknown age and gender. The patient's pertinent medical history, current conditions, previous drug reactions or allergies, and concomitant medications were not reported.   On 24-NOV-2020, the patient was vaccinated with haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB), as prophylaxis (formulation, strength, dose, vaccination scheme, route of administration and anatomical site of vaccination were not reported; lot number T001207, which has been verified to be valid, expiration date reported and validated as 09-JUN-2022). The vaccine administered experienced a temperature excursion of 9.2 degrees Celsius (C), for a time frame of 9 minutes. There was no previous temperature excursion reported and no data logger was involved. No additional adverse events were reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2012USA000913: US-009507513-2012USA000976: US-009507513-2012USA000997:
I started to have trouble breathing and I had very little stamina when I was walking. I experienced panic attacks after there was no diagnosis. I had some heart testing in November of 2020. I wore a monitor and I had a stress test which were negative. My symptoms and shortness of breath got worse. At the end of July I ended up in the hospital and I was diagnosed with Atrial Fibrillation and Congestive Heart Failure.
Intermittent racing fluttering heart; This is a spontaneous report from a contactable consumer (patient). A 40-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), administered in the right arm on 13Mar2021 at 18:30 (at the age of 40-year-old) and the second dose was administered in the left arm on 02Apr2021 at 13:00 (at the age of 40-year-old); both dose were administered via an unspecified route at a pharmacy or drug store facility as SINGLE DOSE for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The patient had no other vaccine in four weeks. The patient had no COVID prior to vaccination and was not COVID tested post vaccination. Medical history included known allergies to Penicillin. The patient was on unspecified concomitant medications. On 20Mar2021, the patient experienced intermittent racing fluttering heart. It started the week after the first shot and intensified the week after he second. No treatment was given for the event. The patient had not yet recovered from the event.  Information on the lot/ batch number has been requested.
Day after vaccine individual had fever. Next 2 morning coughing up blood tinged sputum with pieces of brown mucus. doctor contacted and individual instructed to go to ER for CT scan in case of blood clots. Oxygen stat was 81 when arriving at hospital. Was given oxygen immediately and admitted - staying three days.
Post vaccination, pt became less responsive. Eyes were still open and patient still verbally responding to questions. Pt unable to give eye contact, pupils appeared dilated. Pt began to feel clammy, appeared pale. Assisted pt to wheelchair with MA. Pt's face appeared flush and pt became responsive again. Pt was provided cool juice and cold water. Pt brought to room 16 to lie down. Dr. notified of pt situation. Orthostatics completed. Dr. seen pt at bedside to discuss pt status and plan. Advised pt to continue to stay hydrated and to call SHC with any continuing worsening symptoms or concerns. Pt verbalized understanding.
Fever of 102.8, muscle aches over entire body, extreme migraine and fatigue. Pain and swelling at injection site. Red and hot to the touch.
pt recv vax January or February 1994; Lab testing revealed that was pos for HBc antibody;
PATIENT WAS GIVEN A PFIZER BIVALENT COVID BOOSTER AT APPROXIMATELY 2:50PM TODAY. SHE WAITED IN HER CAR FOR APPROXIMATELY 10 MINUTES THEN RE-ENTERED THE HEALTH DEPARTMENT WITH COMPLAINT OF FEELING "TINGLY". PT DENIED FEELING OF THROAT SWELLING OR SHORTNESS OF BREATH, DENIES CHEST PAIN. STATES SHE FEELS "WOOZY". B/P CHECKED AND WAS 226/94 WITH AUTOMATED CUFF, 220/104 MANUALLY, BOTH IN RIGHT ARM. PULSE 73, O2 SAT 98% ON ROOM AIR, TEMP 97.1. CHEEKS ARE RED BUT PT STATES THEY ARE "ALWAYS THAT WAY". SON ARRIVED AT HEALTH DEPT. PT HAD CALLED HIM WHILE SHE WAS IN HER VEHICLE. EMS DISPATCHED TO HEALTH DEPARTMENT, APN EVALUATED PATIENT AND PHONED MEDICAL DIRECTOR. APN/MD ADVISED TO HOLD EPINEPHRINE AT THIS TIME. EMS EVALUATED PATIENT. SON AND PATIENT DECIDED HE WOULD TAKE HER BY PRIVATE VEHICLE TO ER FOR EVAL OF HER BLOOD PRESSURE. PT REPORTS SHE HAD NOT SEEN PCP SINCE SEPT 2022 AND HER B/P WAS "OK" THEN.
suspected vaccination failure; got shingles / I don't ride bikes or a horse; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows The patient had reported for himself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles. The patient stated that, the patient had a better vaccine at the time of reporting and he/she still took him/her lyrics. He/she stated that, it was almost like been normal. The patient did not ride bikes or a horse. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided.
Redness with orange peel texture, swelling, induration >6 inches, itching, pain at site and left extremity. Headache, extreme tiredness, and fever of 102.3F.
Day 1 had no symptoms. day 2 had arm soreness and internal swelling. day 3-5 soreness began to subside. day 5-7 soreness was gone but the internal swelling was still there. day 9-11 arm started to get itchy and experienced large hives and inflammation. arm was hot to the touch.  Day 13 arm is still hot to touch and swollen. not experiencing hives as i am typing this.
fever; headache; upset stomach; worse pain; I can't move my arm; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had Shingles 2011) and pain (worse pain).   On 27-FEB-2023, the patient received Shingles vaccine. In FEB-2023, an unknown time after receiving Shingles vaccine, the patient experienced fever (Verbatim: fever), headache (Verbatim: headache), upset stomach (Verbatim: upset stomach), pain (Verbatim: worse pain) and mobility decreased (Verbatim: I can't move my arm). The outcome of the fever, headache, upset stomach and mobility decreased were not reported and the outcome of the pain was unknown.   It was unknown if the reporter considered the fever, headache, upset stomach, pain and mobility decreased to be related to Shingles vaccine.     It was unknown if the company considered the fever, headache, upset stomach, pain and mobility decreased to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-Mar-2023 The patient had shingles 10 years ago.  The worse pain. Yesterday (the day before reporting) the patient got the vaccine. The patient said oh lord, he/she had fever, headache, upset stomach and he/she could not move his/her arm. The patient hope he/she would never have shingles anymore. The patient had Shingles 2011, the worse pain.  The patient had the vaccine yesterday, was very bad but better than shingles.  The patient felt blessed.
In December 2021 I noticed redness and flushing on my face.  It was worse after I drank hot beverages.  Specifically, it was on my cheeks and forehead.  It flares up every week or so.  I saw the doctor on March 24, 2023, and was diagnosed with rosacea.  I am also being evaluated for Lupas.  I was prescribed Doxycycline Monohydrate.
DEVELOPED L DELTOID AND UPPER ARM EDEMA, ERYTHEMA, WARMTH, PRURITIC RASH PROGRESSING OVER 2 DAYS, NO SYSTEMIC SYMPTOMS.
Right and left Elbow and the surrounding muscle pain and weakness along with finger(middle joint on all the 5 fingers and on both the hands) joint pain and stiffness.  The pain is still there and sometimes gets worse.
Arm pain; Runny nose; Watery eyes; Sneezing; Allergy; This is a spontaneous report from a contactable consumer (reported for self).   A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the consumer stated that he went to get Pfizer Covid Vaccine on Tuesday evening around 6 o'clock and he just had like normal arm pain but probably on Thursday he started having like runny nose kind of like allergy running nose, watery eyes and he have been having and it's not improving it is getting worse. He has been getting runny nose, watery eyes and also sneezing. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Nine days after receiving vaccine left arm became swollen sore/itchy and painful at  sight where vaccine was administered. I stayed that way until 3/13/21 - 5:00 am. Now it is a bit tender/painful but swelling and being sore and itchy are no longer present.
Covid Pfizer shots 2/24/21 and 3/16/21, On metformin and clomiphene for PCOS. FDLMP 4/6/21. Normally has 39 day cycle. Had a spontaneous abortion at 8 weeks gestation (approximately 6-1-2021). Fetal tissue passed spontaneously without necessitating D&C. Doctor is OB-GYN who recommended the covid shots. Health facility administered the shots. Had never had other pregnancies. Has not yet been reported to VAERS by anyone else.
02/05/2021- After the 15 minute wait, I went to work and ten minutes into drive my left arm became cold, numb, inflamed and swollen, continued for about 2 hours, was radiating toward my fingertips and shoulder. Fever 102.0 for abut 6 hours, no medication needed it subsided.  I also had lethargy, body aches. Within 48 hours all side effects subsided.
Cysts in Ovaries; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 13May2021 13:30 (Lot number: EW0170) at the age of 40 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EW0176, Location of injection: Left Arm, Vaccine Administration Time: 01:30 PM), administration date: 22Apr2021, when the patient was 40 years old, for COVID-19 immunization. The following information was reported: OVARIAN CYST (non-serious) with onset 22Jun2021, outcome "unknown", described as "Cysts in Ovaries". The event "cysts in ovaries" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of ovarian cyst.  Additional information: Facility where the most recent COVID-19 vaccine was administered at Hospital. Patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Patient had not diagnosed with COVID-19 prior to vaccination. Patient had been tested for COVID-19 since the vaccination.  Follow-up attempts are completed. No further information is expected.
elevated temp below 102 from 11FEB97 to 14FEB97;10PM t106, lethargy, taken to ER 14FEB97;clear, nasal drainage-small amount;ceclor started 14FEB x 1wk;no further inc temp p/18FEB97;
On jan 23rd 2021, about 5 minutes after initial covid vaccine and during the 15 minute on site observation, patient reported today that she experienced bilateral neck "tingling" that resolved spontaneously and appeared without any associated symptoms. She has not experienced any other adverse reactions since. She denied any SOB, wheezing, difficulty breathing, swelling, facial flushing.  She did not report this to anyone on site at the time and presented today for her second dose, which is when she informed us of this experience.  Per protocol, patient did not obtain second dose of covid vaccine.  MD and site lead present at time of interaction.